Michael Drazer

Michael Drazer is an Assistant Professor at the University of Chicago, Department of Medicine-Hematology and Oncology. His research integrates genomics and human genetics to understand mechanisms driving hereditary blood and cancer syndromes, focusing on developing high-fidelity cellular and mouse models and clinical bioinformatics pipelines for improved diagnosis.

• Education: BA/BS in Biochemistry/Biology/English (Indiana University), PhD in Human Genetics (University of Chicago), MD (University of Chicago)
• Postgraduate Training: Residency in Internal Medicine, Fellowship in Hematology/Oncology (University of Chicago)

Research spans hereditary hematologic malignancies, germline variants, and cancer predisposition, with recent work on CHEK2, RUNX1, and ERG mutations. His clinical research optimizes care for patients with hereditary cancer syndromes, including thromboembolic risk in mesothelioma and genomic profiling protocols.

Publications trend toward hematology (62%) and neoplasms (58%), with growing emphasis on genetics and bioinformatics. Collaborations include Lucy Godley, Anand Patel, and Hedy Kindler.

He leads the Drazer Group at the University of Chicago Comprehensive Cancer Center, focusing on syndrome discovery and patient avatars for precision medicine. His work addresses gaps in genetic testing quality and clinical surveillance for hereditary cancers.